Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
Objective: Bendamustine was approved for treating chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Despite its therapeutic benefits, the long-term safety of bendamustine in a large population remains inadequately understood. This study evaluates the adverse events (AEs) associa...
Saved in:
Main Authors: | Dan Li (Author), Yuan Zhang (Author), Jia Qi Ni (Author), Juan Zhu (Author), Wen Ting Lu (Author), Ya Lin Chen (Author), Lei Cheng (Author), Yu Qi Wang (Author), Qian Jiang Li (Author), Jie Wang (Author), Yan Bing Lu (Author), Jia Chen (Author), Li Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database
by: Xiaodan Zhou, et al.
Published: (2024) -
The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database
by: Xiaogan Wang, et al.
Published: (2024) -
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
by: Fan Zou, et al.
Published: (2023) -
Safety assessment of tranexamic acid: real-world adverse event analysis from the FAERS database
by: Ningsheng Tian, et al.
Published: (2024) -
Signal detection and analysis of adverse events associated with Genvoya® based the FAERS database
by: Chengliang Wang, et al.
Published: (2024)